Platinum Sensitive research hub

Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy

This study looks at a drug called Olaparib for women with a specific type of ovarian cancer. It's for those whose cancer has improved after chemotherapy and have a change in their BRCA gene. We want to see if Olaparib helps keep the cancer away longer.